YOUNG JAMES F

Average Profitability
66.45%
Insider Buys Quantity
5
Insider Buys Sum
$1.74M
Insider Sells Quantity
9
Insider Sells Sum
$7.14M

Insider Activity of YOUNG JAMES F

According to the SEC Form 4 filings, YOUNG JAMES F, being in a position of

  1. director at Novavax, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 15000 shares for $208,556,
    over all time since 2011-12-01, has bought 853000 shares for $1.74M, and sold 701050 shares for $7.14M.

The largest purchase of all time was on 2011-12-01 and amounted to 400000 shares of Novavax, Inc. for $584,000.

The largest sale of all time was on 2020-12-31 and amounted to 22000 shares of Novavax, Inc. for $2.49M.

Biography of YOUNG JAMES F

No biography is available at this moment.

2024-06-21SaleNovavax, Inc.
NVAX
director
7,500
0.0045%
$14.09$105,675-9.29%
2024-06-18SaleNovavax, Inc.
NVAX
director
7,500
0.0044%
$13.72$102,881-7.32%
2022-03-31SaleNovavax, Inc.
NVAX
300
0.0004%
$75.10$22,531-69.53%
2021-12-31SaleNovavax, Inc.
NVAX
director
3,750
0.0049%
$144.16$540,601-64.98%
2021-03-23SaleNovavax, Inc.
NVAX
director
10,000
0.0142%
$228.22$2.28M-19.12%
2020-12-31SaleNovavax, Inc.
NVAX
director
22,000
0.0305%
$113.09$2.49M+69.31%
2020-06-03PurchaseNovavax, Inc.
NVAX
director
3,000
0.0056%
$48.83$146,490+186.14%
2017-08-31SaleNovavax, Inc.
NVAX
director
350,000
0.1188%
$1.06$369,740+36.19%
2017-03-14SaleNovavax, Inc.
NVAX
director
200,000
0.0735%
$1.39$277,960-15.94%
2015-06-18SaleNovavax, Inc.
NVAX
director
100,000
0.0371%
$9.47$947,230-26.39%
2014-03-25PurchaseNovavax, Inc.
NVAX
director
50,000
0.0239%
$4.47$223,675+6.81%
2013-06-06PurchaseNovavax, Inc.
NVAX
director
200,000
0.128%
$1.91$382,000+95.66%
2013-03-11PurchaseNovavax, Inc.
NVAX
director
200,000
0.1328%
$2.03$406,000+40.78%
2011-12-01PurchaseNovavax, Inc.
NVAX
director
400,000
0.3485%
$1.46$584,000+2.88%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.